Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maguire

Showing results (561-570 of 566) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 566 results.
NAR Cancer|July 28, 2021
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicitySophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Journal of Medicinal Chemistry|April 1, 2011
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitorsVincent Mascitti, Tristan S Maurer, Ralph P Robinson, et al.
Wellcome Open Research|November 6, 2020
Baseline results of a living systematic review for COVID-19 clinical trial registrationsBrittany J Maguire, Alistair R D McLean, Sumayyah Rashan, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 57

Showing results (561-570 of 566) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 566 results.
NAR Cancer|July 28, 2021
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicitySophia Gayle, Robert Aiello, Nalin Leelatian, et al.
Bioorganic & Medicinal Chemistry Letters|July 9, 2013
Pyrimidone-based series of glucokinase activators with alternative donor-acceptor motifKevin J Filipski, Angel Guzman-Perez, Jianwei Bian, et al.
Journal of Medicinal Chemistry|April 1, 2011
Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitorsVincent Mascitti, Tristan S Maurer, Ralph P Robinson, et al.
Wellcome Open Research|November 6, 2020
Baseline results of a living systematic review for COVID-19 clinical trial registrationsBrittany J Maguire, Alistair R D McLean, Sumayyah Rashan, et al.
British Journal of Pharmacology|February 18, 2014
The Concise Guide to PHARMACOLOGY 2013/14: overviewStephen P H Alexander, Helen E Benson, Elena Faccenda, et al.
British Journal of Pharmacology|December 29, 2025
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptorsStephen P H Alexander, Anthony P Davenport, Eamonn Kelly, et al.
Pageof 57